Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Maternal gut microbiome and its impact on developing idiopathic late fetal growth retardation

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.547

Abstract

Aim: to analyze a rectal microbiome composition in pregnant women and assess its potential impact on developing of idiopathic late fetal growth retardation (FGR) syndrome.

Materials and Methods. We analyzed a course of pregnancy and labour in 80 pregnant women: main group consisted of 40 pregnant women with FGR, control group – of 40 healthy pregnant women. The analysis of the intestinal microbiota in 53 pregnant women (25 pregnant women with late FGR and 28 healthy pregnant women) was carried out by using nitrogenous base sequencing in the 16S ribosomal RNA (rRNA) genes.

Results. Analyses of the gut microbiome composition in pregnant women in study groups revealed significant differences particularly showing a 1.0 % increase in the proportion of Clostridiales Ruminococcaceae Oscillospira that correlated with a 331.7 g increase in neonatal weight gain; a 1.0 % increase in the level of Coriobacteriales Coriobacteriaceae Collinsella was associated with a 476.2 g decrease in neonatal weight gain. The Firmicutes/Bacteroides ratio was 2,0 and 3.6 in main and control group (p = 0.02), respectively, which may suggest about a microbiological dysbiosis with putative pathophysiological outcomes. A significant association between elevated leucocyte counts (in the absence of other manifestations of inflammatory processes) and the probability of FGR development was found. A white blood cell count ≥ 11.05×109/L predicted the risk of FGR with a sensitivity of 60.6 % and a specificity of 79.2 %. Also, erythrocyte sedimentation rate level of ≥ 41.5 mm/hour was associated with increased FGR risk, demonstrating a sensitivity of 85.7 % and specificity of 70.6 %.

Conclusion. It can be concluded that gut dysbiosis may play a role in development of late idiopathic FGR. A negative correlation between a decreased Firmicutes/Bacteroides ratio as well as higher Actinobacteria proportion and fetal birth weight was found.

About the Authors

M. E. Zhelezova
Kazan (Volga Region) Federal University
Russian Federation

Maria E. Zhelezova, MD, Dr Sci Med, Prof.

74 Karl Marks Str., Kazan 420012



B. К. Bektur
Nuriev Clinic LLC
Russian Federation

Begimai Bektur kyzy, MD.

40a Brothers Kasimov Str., Kazan 420110



L. I. Maltseva
Kazan State Medical Academy – Branch of the Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
Russian Federation

Larisa I. Maltseva, MD, Dr Sci Med, Prof.

36 Butlerova Str., Kazan 420015



R. I. Sharipova
Kazan (Volga Region) Federal University
Russian Federation

Rezeda I. Sharipova, MD, PhD

74 Karl Marks Str., Kazan 420012



D. B. Shakirzyanova
Kazan (Volga Region) Federal University
Russian Federation

Dana B. Shakirzyanova

74 Karl Marks Str., Kazan 420012



References

1. . Clinical guidelines – Insufficient fetal growth requiring maternalmedical care (fetal growth retardation) – 2022-2023-2024 (14.02.2022). [Klinicheskie rekomendacii – Nedostatochnyj rost ploda, trebuyushchij predostavleniya medicinskoj pomoshchi materi (zaderzhka rosta ploda) – 2022-2023-2024 (14.02.2022). Moscow: Ministerstvo zdravoohraneniya Rossiijskoj Federacii, 2022. 47 p. (In Russ.). Available at: https://cr.minzdrav.gov.ru/recomend/722_1. [Accessed: 14.07.2024].

2. Centers for Disease Control and Prevention (CDC). World Health Organization, 2021. Available at: https://www.who.int/teams/regulationprequalification/regulation-and-safety/pharmacovigilance/networks/vaccine-safety-net/vsn-members/centers-for-disease-control-andprevention. [Accessed: 14.07.2024].

3. MacLeod R., Paulson J.N., Okalany N. et al. Intraventricular haemorrhage in a Ugandan cohort of low-birth weight neonates: the IVHU study. BMC Pediatr. 2021;21(1):12. https://doi.org/10.1186/s12887-020-02464-4.

4. Dinu M., Stancioi-Cismaru A.F., Gheonea M. et al. Intrauterine growth restriction – prediction and peripartum data on hospital care. Medicina. 2023;59(4):773. https://doi.org/10.3390/medicina59040773.

5. Kaplina A., Kononova S., Zaikova E. et al. Necrotizing enterocolitis: the role of hypoxia, gut microbiome, and microbial metabolites. Int J Mol Sci. 2023;24(3):2471. https://doi.org/10.3390/ijms24032471.

6. Fernandez-Rodriguez B., de Alba C., Galindo A. et al. Obstetric and pediatric growth charts for the detection of late-onset fetal growth restriction and neonatal adverse outcomes. J Perinat Med. 2020;49(2):216–24. https://doi.org/10.1515/jpm-2020-0210.

7. Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32(3):213–8. https://doi.org/10.1053/j.semperi.2007.11.005.

8. Børte S., Winsvold B.S., Stensland S.Ø. et al. The effect of fetal growth restriction on the development of migraine and tension-type headache in adulthood. The HUNT Study. PLoS One. 2017;12(4):e0175908. https://doi.org/10.1371/journal.pone.0175908.

9. Hu J., Benny P., Wang M. et al. Intrauterine growth restriction is associated with unique features of the reproductive microbiome. Reprod Sci. 2021;28(3):828–37. https://doi.org/10.1007/s43032-020-00374-5.

10. Tu X., Duan C., Lin B. et al. Characteristics of the gut microbiota in pregnant women with fetal growth restriction. BMC Pregnancy Childbirth. 2022;22(1):297. https://doi.org/10.1186/s12884-022-04635-w.

11. Miao T., Yu Y., Sun J. et al. Decrease in abundance of bacteria of the genus Bifidobacterium in gut microbiota may be related to pre-eclampsia progression in women from East China. Food Nutr Res. 2021;65. https://doi.org/10.29219/fnr.V65.5781.

12. Li G., Yin P., Chu S. et al. Correlation analysis between FGR and gut microbial composition in late pregnancy. J Diabetes Res. 2021;2021:8892849. https://doi.org/10.1155/2021/8892849.

13. Kyono K., Hashimoto T., Nagai Y., Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol. 2018;17(3):297–306. https://doi.org/10.1002/rmb2.12105.

14. Yao Y., Cai X., Chen C. et al. The role of microbiomes in pregnant women and offspring: research progress of recent years. Front Pharmacol. 2020;11:643. https://doi.org/10.3389/fphar.2020.00643.

15. Cadaret C.N., Posont R.J., Beede K.A. et al. Maternal inflammation at midgestation impairs subsequent fetal myoblast function and skeletal muscle growth in rats, resulting in intrauterine growth restriction at term. Transl Anim Sci. 2019;3(2):txz037. https://doi.org/10.1093/tas/txz037.

16. Zhelezova M.E., Bektur B.K., Maltseva L.I., et al. Influence of the maternal microbiome on the development of late fetal growth retardation. [Znachenie materinskogo mikrobioma v razvitii pozdnej zaderzhki rosta ploda]. Prakticheskaya medicina. 2022;20(5):34–9. (In Russ.). https://doi.org/10.32000/2072-1757-2022-5-34-39.

17. Sokol H., Seksik P., Furet J.P. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–9. https://doi.org/10.1002/ibd.20903.

18. Dudun A.A., Bonartsev A.P., Zharkova I.G., Voinova V.V. The role of intestinal microbiota in the treatment of various diseases and new generation antibacterial drugs. Study guide. [Rol' kishechnoj mikrobioty v lechenii razlichnyh zabolevanij i antibakterial'nye preparaty novogo pokoleniya. Uchebno-metodicheskoe posobie]. Moscow: Mir nauki, 2020. 129 p. (In Russ.). Available at: https://izd-mn.com/PDF/17MNNPU20.pdf. [Accessed: 14.07.2024].

19. Mizgier М., Jarzabek-Bielecka G., Mruczyk K., Kedzia W. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women. Ginekol Pol. 2020;91(7):412–6. https://doi.org/10.5603/GP.2020.0070.

20. Gorczyca K., Obuchowska A., Kimber-Trojnar Ż. et al. Changes in the gut microbiome and pathologies in pregnancy. Int J Environ Res Public Health. 2022;19(16):9961. https://doi.org/10.3390/ijerph19169961.

21. Koren O., Goodrich J.K., Cullender T.C. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. https://doi.org/10.1016/j.cell.2012.07.008.

22. Zixin T., Yun Ch., Fang H. et al. Alterations in the gut microbiome and metabolisms in pregnancies with fetal growth restriction. Microbiol Spectr. 2023;11(3):e00076-23. https://doi.org/10.1128/spectrum.00076-23.

23. Jin J., Gao L., Zou X. et al. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res. 2022;131(6):492–506. https://doi.org/10.1161/CIRCRESAHA.122.320771.

24. Salafia C.M., Ernst L.M., Pezzullo J.C. et al. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995;12(2):106–10. https://doi.org/10.1055/s-2007-994417.

25. Marcorelles P. Placental features in intrauterine growth retardation. J Gynecol Obstet Biol Reprod. 2013;42(8):996–1007. (In French). https://doi.org/10.1016/j.jgyn.2013.09.021.


What is already known about this subject?

► Late fetal growth retardation (FGR) remains one of the understudied pathologies, and questions related to its pathogenesis, prevention and treatment are still unanswered.

► FGR is a cause for perinatal and adult delayed complications.

What are the new findings?

► Significant associations between gut microbiome in pregnant women and fetal weight at birth were found.

► A regression model for assessing a relationship between newborn birth weight and the percentage of rectal Corio-
bacteriales Coriobacteriaceae Collinsella
in pregnant women was constructed.

► It was found that inflammatory diseases of the lower genital tract and manifestation of urinary infection are more frequent at gestational age of 28–32 weeks, which may be a critical period for late FGR development.

How might it impact on clinical practice in the foreseeable future?

► Monitoring and managing inflammatory processes through analysis of the gut microbiome and inflammatory markers may reduce a risk of developing FGR-associated complications.

► Improving the monitoring and prevention of infectious and inflammatory diseases in pregnant women at gestational age of 28–32 weeks may reduce a risk of late FGR development.

► Personalized approach to correct maternal microbiome may become a new direction in prevention and treatment of perinatal complications, which may improve pregnancy outcomes.

Review

For citations:


Zhelezova M.E., Bektur B.К., Maltseva L.I., Sharipova R.I., Shakirzyanova D.B. Maternal gut microbiome and its impact on developing idiopathic late fetal growth retardation. Obstetrics, Gynecology and Reproduction. 2024;18(6):788-799. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.547

Views: 454


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)